Menu Menu

CLGN    Collplant Biotechnologies Ltd    1631487    
Income Statement
Revenue 249,000
Net Income -4,210,000
Profit Margin -1690.76%

Balance Sheet
Current Assets 20,335,000
Assets 26,566,000
Current Liabilities 3,241,000
Liabilities 5,837,000
Equity 20,729,000
Shares Out 11,455,000

Cash Flow Statement
Operating Cash Flow -7,181,000
Investing Cash Flow -341,000

Market Analysis
Market Cap 57,271,400
Price 4.03
BVPS 1.81
PB 2.24
EPS -1.53
PS 115.00
FCF -7,522,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
Apr May Jun
4/04 5/29 -0.35
Jul Aug Sep
8/20 -0.37
Oct Nov Dec
11/21

Find a discrepancy? The most accurate way to find company fundamental data is to view CLGN documents filed with the SEC.


CLGN Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: